Goodbody Health progressing on all fronts as demand soars (AQSE:GDBY)

Goodbody Health Inc. (AQSE:GDBY) Chief Executive Officer Marc Howells caught up with DirectorsTalk for an exclusive interview to discuss the under-resourced and overburden NHS, the change in how people are managing their health, how they are meeting the massive growing demand for services and continuing to grow at speed.

Q1: COVID has created this perfect storm of rising health-related risks in the UK population at a time when the NHS is under-resourced and overburdened. What’s your view on this?

A1: Firstly, I’d say that I think we all as a nation applaud the employees of the NHS for the amazing work that they do and for what they’ve been able to do over such an unprecedented pandemic.

However, if we go back a couple of years, even before the pandemic, it was very clear the excessive backlogs were building up in the NHS and its ability to meet the demand with the capacity it had. Add into that what happened on Brexit and post-Brexit, a significant number of people being repatriating to their own countries. You then layer the pandemic on top of that which has significantly changed people’s attitude towards their health and position on their health. It’s just created a perfect storm for the NHS where it’s struggling to keep up with the backlog and it’s even forecasting those backlogs will increase over the next five years so it’s a very challenging time for the NHS.

One of the results of the pandemic as well is that people are far more inquisitive on their health and want to take more control of their health, not just on diagnostics and treatment but also on prevention. People are now used to going into the pharmacist and going into their doctors to enquire about their health without waiting for symptoms or without waiting to feel poorly. So, there’s a huge increase in customer awareness, customer desire to know more about their health and that’s impacting on an already over-stretched NHS.

Q2: Given that dismal backdrop, are we really seeing a change in how people manage their health?

A2: We are, and you can see that with the incredible increase of people requesting blood tests, requesting allergy tests, requesting intolerance tests. Just to put it into perspective, the vitamin business alone in the UK is a £1.5 billion business and that’s grown exponentially during the pandemic and since the pandemic.

So, you can see that people are taking more control over their health, over feeling well as you know, in Goodbody Health we use the phrase ‘Know More, Live Better’, that it’s know more about your health, know more about what your blood is telling you and be able to manage and control the outcomes and manage your lifestyle. We believe wellness I very much a lifestyle choice. If you look at the millennials today, they’re actually called ‘the wellness generation’ and that is managing and taking control of their wellness rather than just relying purely on the NHS.

If you look at the situation we have in the country and how it’s historically developed, you never check your blood, you go to the doctor when you’re feeling unwell and the doctor will take a blood test or instruct a blood test and then determine the results of that. You check your car on a regular basis, you check your boiler on a regular basis and you go to the dentist at least twice if not more a year to check your teeth but there’s not a culture in place of checking your blood which is probably the biggest commodity that you have, it determines how healthy you are.

So, we’re seeing a significant increase now in people wanting to check their blood to determine their wellness and determine their health and have more access to that information so that they can control and manage it as they move forward.

Q3: How is the company meeting the massive growing demand for your services?

A3: As fast as we can. We’re bringing innovative technology into the industry, we now operate through over 200 pharmacies, we have devices that will mean that you do not have to go into the doctor, have your blood taken at the doctors, go through a courier, go to the lab and experience the huge time delays doing that. You can go into one of our pharmacy’s and have a blood test with the results in several minutes, not five plus weeks.

The devices we’re using are Abbott devices which are NHS-approved devices and we have those in 111 pharmacies today and we’ve grown that network as fast as we can. We’re trying to achieve that through bringing in the technology into the local pharmacies because the pharmacies are in the position of offering these services outside of the general NHS.

Q4: It looks as though Goodbody Health is developing into an impressive health provider. Can you continue to grow at speed?

A4: Absolutely. I’m acquiring these devices as fast as I can, we are signing up pharmacies as  fast as we can, there’s more innovative technology coming into the market which we’ll announce in the near future, that’s very exciting and enables to continue to disrupt the existing market. There are 11,700 pharmacies out there and we’re currently in 200 so there’s a huge opportunity to extend our services over the existing market and experience in the UK to allow people on a national basis to have access to their blood and to what their blood is telling them.

So, we’re very exciting about our growth plan and how we’re executing that growth.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
Goodbody Health Inc.

More articles like this

Goodbody Health Inc.

Goodbody Health appoints George Thomas as new CEO

Goodbody Health Limited (AQSE:GDBY) has announced that Marc Howells has resigned from the Board as Chief Executive Officer, with immediate effect.  The Company wishes to thank Marc for his contribution to the Company. George Thomas, an

Goodbody Health Inc.

Good cholesterol may not protect against heart disease

For decades doctors have been telling their patients that high levels of HDL, otherwise known as “good cholesterol,” could protect them from heart disease. But a new study suggests that having a lot of so-called good

Goodbody Health Inc.

Andy Taylor’s terminal prostate cancer diagnosis

Heartbroken fans have shown their support for Duran Duran’s Andy Taylor after it emerged he’s battling cancer.  Bandmate Simon Le Bon broke the news on Sunday as he read out a letter from the guitarist and said Taylor

Goodbody Health Inc.

Symptoms of high cholesterol

High Cholesterol can be a silent development, making it all the more dangerous. But often, other parts of the body – like your feet or nails – can show some symptoms that may be indicative of

Goodbody Health Inc.

How to manage prediabetes and prevent diabetes

Prediabetes occurs when blood sugar levels are higher than normal but not quite at the level of diabetes. High blood sugar levels occur in prediabetes when the body does not properly respond to insulin (a hormone that allows cells

Goodbody Health Inc.

How to spot the symptoms of prostate cancer

Talking (and reading) about cancer can be difficult, but did you know that one in eight men will get prostate cancer at some point in their life? It’s the most common cancer in men, but some most

Goodbody Health Inc.

High Cholesterol: What it means and how to treat it

Have you had your lipid panel checked recently? Were you told you have high cholesterol? If so, you are among approximately 94 million adult Americans with cholesterol levels over normal ranges. This condition, referred to as dyslipidemia

Goodbody Health Inc.

Prostate cancer symptoms and treatment: What to check for

Bill Turnbull’s campaigning saved lives and encouraged “thousands and thousands” of men to come forward for prostate cancer testing, experts say. The broadcaster died from the disease, at the age of 66. When Turnbull revealed his

Goodbody Health Inc.

Symptoms of prediabetes

Approximately 38% of adults and 28% of children in the United States have prediabetes, a health condition associated with abnormally high blood sugar levels.1 While blood sugar (glucose) levels are elevated in prediabetes, they are not high enough

Goodbody Health Inc.

Goodbody Health wins distribution contract

Goodbody Health announced that that it has signed a contract with Tasso Inc, the leading provider of convenient, clinical grade blood collection solutions, for the UK pharmacy and wellness market. Tasso produces a signature line of

Goodbody Health Inc.

Goodbody Health signs distribution contract with Tasso

Goodbody Health Inc (AQSE:GDBY) has announced that it has signed a contract with Tasso Inc, the leading provider of convenient, clinical grade blood collection solutions, for the UK pharmacy and wellness market. Tasso produces a signature

Goodbody Health Inc.

6 Simple steps to a happy, healthy heart

Heart health is really important, but it’s not just about taking the right supplements. It’s important to follow this emotional health advice, too It is interesting how many people shun emotional health advice. They believe that heart health

Goodbody Health Inc.

Kenny Logan: Rugby hero reveals prostate cancer shock

Former Scotland international Kenny Logan has revealed his “huge shock” at being diagnosed with prostate cancer. Logan, who won 70 caps for his country, was given the news in February. “It’s hard because when you’re told

Goodbody Health Inc.

Unusual signs and symptoms of raised cholesterol

Many people only become aware for the first time that they have a high cholesterol level, when they are admitted to hospital with a heart attack Unfortunately, there are usually very few clinical signs of raised

Goodbody Health Inc.

Understanding prediabetes

Prediabetes is a diagnosis where your blood sugar levels are higher than normal, but not high enough to be considered diabetes. There are a lot of misconceptions and a general lack of concern around this condition

Goodbody Health Inc.

Goodbody Health H1 revenue 52% higher than 2021

Goodbody Health Inc (AQSE:GDBY) has announced its half year 2022 unaudited Interim Financial Statements for the six months to 30 June 2022. The revenue at £7.40m was £2.55m higher than the comparative period in 2021. As